Results indicate a reduction in ATM signaling in the frontal cortex, whereas increased ATM levels were reported in the cerebellum of AD patients, pointing to specific roles of this kinase in brain areas diversely affected by the pathology [110]. This evidence concerns the gene ATM and Alzheimer disease.